AmerisourceBergen Corporation

117.12-0.4200-0.36%Vol 1.04M1Y Perf 36.92%
Apr 13th, 2021 16:00 DELAYED
BID115.18 ASK118.90
Open116.89 Previous Close117.54
Pre-Market- After-Market117.12
 - -  - -%
Target Price
127.11 
Analyst Rating
Moderate Buy 2.22
Potential %
8.53 
Finscreener Ranking
     41.06
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     40.68
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
     37.12
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★★     45.89
Market Cap23.98B 
Earnings Rating
Neutral
Price Range Ratio 52W %
91.24 
Earnings Date
5th May 2021

Today's Price Range

116.26117.27

52W Range

81.51120.54

5 Year PE Ratio Range

-104.7064.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.55%
1 Month
3.72%
3 Months
10.87%
6 Months
19.47%
1 Year
36.92%
3 Years
34.90%
5 Years
36.22%
10 Years
215.40%

TickerPriceChg.Chg.%
ABC117.12-0.4200-0.36
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Financial StrengthValueIndustryS&P 500US Markets
0.60
1.00
0.48
1.07
-32.00
Leverage Ratio -52.30
ProfitabilityValueIndustryS&P 500US Markets
2.80
-2.50
-2.30
0.00
-3.07
RevenueValueIndustryS&P 500US Markets
147.13B
718.73
2.91
4.96
DividendsValueIndustryS&P 500US Markets
1.50
1.76
4.00
5.79
Payout ratio21.00
Earnings HistoryEstimateReportedSurprise %
Q01 20211.942.1812.37
Q04 20201.871.891.07
Q03 20201.581.8517.09
Q02 20202.282.405.26
Q01 20201.671.765.39
Q04 20191.581.611.90
Q03 20191.631.767.98
Q02 20191.962.117.65
Earnings Per EndEstimateRevision %Trend
3/2021 QR2.500.00-
6/2021 QR1.95-2.01Negative
9/2021 FY8.531.79Positive
9/2022 FY9.935.98Positive
Next Report Date5th May 2021
Estimated EPS Next Report2.50
Estimates Count7
EPS Growth Next 5 Years %11.40
Volume Overview
Volume1.04M
Shares Outstanding204.71M
Trades Count15.36K
Dollar Volume149.45M
Avg. Volume1.18M
Avg. Weekly Volume772.77K
Avg. Monthly Volume944.93K
Avg. Quarterly Volume1.10M

AmerisourceBergen Corporation (NYSE: ABC) stock closed at 117.12 per share at the end of the most recent trading day (a -0.36% change compared to the prior day closing price) with a volume of 1.21M shares and market capitalization of 23.98B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 22000 people. AmerisourceBergen Corporation CEO is Steven H. Collis.

The one-year performance of AmerisourceBergen Corporation stock is 36.92%, while year-to-date (YTD) performance is 19.8%. ABC stock has a five-year performance of 36.22%. Its 52-week range is between 81.51 and 120.54, which gives ABC stock a 52-week price range ratio of 91.24%

AmerisourceBergen Corporation currently has a PE ratio of -7.30, a price-to-book (PB) ratio of 5.58, a price-to-sale (PS) ratio of 0.16, a price to cashflow ratio of 8.00, a PEG ratio of 2.32, a ROA of -7.21%, a ROC of -61.85% and a ROE of -255.72%. The company’s profit margin is -3.07%, its EBITDA margin is -2.30%, and its revenue ttm is $147.13 Billion , which makes it $718.73 revenue per share.

Of the last four earnings reports from AmerisourceBergen Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.50 for the next earnings report. AmerisourceBergen Corporation’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for AmerisourceBergen Corporation is Moderate Buy (2.22), with a target price of $127.11, which is +8.53% compared to the current price. The earnings rating for AmerisourceBergen Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AmerisourceBergen Corporation has a dividend yield of 1.50% with a dividend per share of $1.76 and a payout ratio of 21.00%.

AmerisourceBergen Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.26, ATR14 : 3.20, CCI20 : 28.99, Chaikin Money Flow : 0.10, MACD : 1.90, Money Flow Index : 54.03, ROC : -0.19, RSI : 62.33, STOCH (14,3) : 51.90, STOCH RSI : 0.93, UO : 55.66, Williams %R : -48.10), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AmerisourceBergen Corporation in the last 12-months were: Gina K. Clark (Option Excercise at a value of $1 319 739), Gina K. Clark (Sold 27 599 shares of value $2 848 252 ), Henry W. McGee (Option Excercise at a value of $0), Henry W. McGee (Sold 5 801 shares of value $609 160 ), James F. Cleary (Option Excercise at a value of $0), Jane E Henney (Option Excercise at a value of $264 106), Jane E Henney (Sold 7 056 shares of value $691 417 ), John G. Chou (Option Excercise at a value of $3 225 438), John G. Chou (Sold 45 298 shares of value $4 526 221 ), Kathleen W. Hyle (Option Excercise at a value of $115 472), Kathleen W. Hyle (Sold 3 085 shares of value $335 617 ), Lazarus Krikorian (Option Excercise at a value of $2 947 336), Lazarus Krikorian (Sold 35 622 shares of value $3 736 326 ), Lon R. Greenberg (Option Excercise at a value of $0), Mark M.D. Durcan (Option Excercise at a value of $0), Richard W. Gochnauer (Option Excercise at a value of $792 393), Richard W. Gochnauer (Sold 21 170 shares of value $1 909 111 ), Robert P. Mauch (Option Excercise at a value of $7 735 188), Robert P. Mauch (Sold 120 431 shares of value $11 910 816 ), Steven H. Collis (Option Excercise at a value of $13 749 730), Steven H. Collis (Sold 179 481 shares of value $19 034 937 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (44.44 %)
4 (44.44 %)
4 (36.36 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (44.44 %)
4 (44.44 %)
6 (54.55 %)
Moderate Sell
1 (11.11 %)
1 (11.11 %)
1 (9.09 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.22
Moderate Buy
2.22
Moderate Buy
2.36

AmerisourceBergen Corporation

AmerisourceBergen is a leading global third-party logistics provider engaged in wholesale pharmaceutical sourcing and distribution of specialty, brand-name, and generic pharmaceuticals and related services to acute-care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, dialysis clinics, and other healthcare customers. By acquiring smaller companies, management has attained the ability to transport biopharmaceuticals, distribute veterinary pharmaceuticals and vaccines, and provide inventory and reimbursement consulting services to providers.

CEO: Steven H. Collis

Telephone: +1 610 727-7000

Address: 1300 Morris Drive, Chesterbrook 19087-5594, PA, US

Number of employees: 22 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

67%33%

News

Stocktwits